According to the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the most frequent side effects include: Nausea very common, often most pronounced when starting treatment or increasing the dose Diarrhoea very common, can range from mild to moderate in severity Vomiting very common, may occur particularly during dose escalation Constipation very common, affects a significant proportion of patients Abdominal pain or discomfort common, typically transient Decreased appetite very common, related to the medication's mechanism of action These gastrointestinal symptoms are usually mild to moderate and tend to improve over time as the body adjusts to the medication
Individuals who already receive GLP-1 medications through their existing Medicare prescription drug coverage or are eligible for separate Medicare GLP-1 coverage, Medicare Part D, are excluded
Raithel M, Hagel AF, Zopf Y, et al
A few commenters encouraged CMS to support data infrastructure improvements, such as automating quality reporting, aligning state reporting standards, and exploring use of the Trusted Exchange Framework and Common Agreement (TEFCA) for data sharing
Choosing Zone.Health means choosing a partner in your health journey, dedicated to helping you achieve lasting wellness
Common cycle structures include: 8-week cycle for beginners 12-week cycle for intermediate users 1216 weeks maximum in most experimental settings After completing a cycle, many individuals take a 24 week break before starting another cycle
